Healthtech funding in Q4 2023
European Healthtech startup funding raised during Q4 2023.
In Q4 2023, 120 European Healthtech companies closed 121 funding rounds and raised €771M in equity funding (excluding debt and grants), down 54.8% versus Q4 2022. Debt rounds added €66M. France led by capital raised, and Fongit Innovation Fund (FIF) was the most active investor. Data as of 20 Nov 2026.
Equity funding
€771M
-54.8% vs Q4 2022 · excl. debt & grants · +€66M debt
Funding rounds
121
-33.5% vs Q4 2022
Companies
120
Top country
France
Rank among sectors
#6
4.7% of sector funding
Debt financing
€66M
7.7% of total
Top-10 round share
60.4%
of disclosed capital
Rounds ≥ €100M
1
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q4 2023 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Oct | €321M | 44 |
| Nov | €286M | 45 |
| Dec | €251M | 32 |
Top countries
by € raisedHealthtech — top countries by capital, Q4 2023 — interactive chart.
Data table
| Healthtech — top countries by capital, Q4 2023 | |
|---|---|
| France | €235M |
| UK | €190M |
| Belgium | €105M |
| Netherlands | €78M |
| Denmark | €54M |
| Germany | €44M |
| Switzerland | €41M |
| Spain | €38M |
Stage mix
by € raisedHealthtech — stage mix, Q4 2023 — interactive chart.
Data table
| Healthtech — stage mix, Q4 2023 | |
|---|---|
| Other | €354M |
| Series A | €197M |
| Series C | €121M |
| Debt | €66M |
| Seed | €59M |
| Series B | €32M |
| Grant | €19M |
| Pre-Seed | €7.8M |
| Early VC | €1.0M |
Top deals
largest disclosed rounds in Q4 2023| Company | Stage | Date | Amount |
|---|---|---|---|
| Aqemia | Other | Dec 2023 | €129M |
| Agomab Therapeutics | Series C | Oct 2023 | €95M |
| EyeBiotech | Series A | Nov 2023 | €61M |
| MinervaX | Other | Oct 2023 | €54M |
| In Ovo | Debt | Nov 2023 | €40M |
| Automata Technologies | Other | Oct 2023 | €38M |
| Eligo Bioscience | Series B | Dec 2023 | €28M |
| Memo Therapeutics | Series C | Nov 2023 | €26M |
| Bioserenity | Other | Nov 2023 | €24M |
| ViaNautis | Series A | Nov 2023 | €23M |
| Cradle | Series A | Nov 2023 | €22M |
| LUMA Vision | Series A | Dec 2023 | €20M |
| Inbrain Neuroelectronics | Debt | Dec 2023 | €20M |
| Lottie | Series A | Oct 2023 | €20M |
| Laverock Therapeutics | Seed | Oct 2023 | €16M |
Top investors
most active in Q4 2023, by deal count- Fongit Innovation Fund (FIF)3 deals
- High-Tech Gründerfonds (HTGF)3 deals
- Sanofi Ventures3 deals
- UI Investissement3 deals
- Verve Ventures3 deals
- Adjuvant Capital2 deals
- Calm Storm Ventures2 deals
- Cleverage Venture Capital2 deals
- Eli lilly and company2 deals
- EQT Life Sciences2 deals